News

The Pharma Letter36m

FDA slaps CRL on PTC Therapeutics’ vatiquinone NDA

PTC Therapeutics yesterday revealed that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL ...

PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital

PTC Therapeutics (PTCT) on Tuesday announced that they received a complete response letter for vatiquinone in Friedreich’s ...